PropertyValue
?:abstract
  • To the Editor: Reported cutaneous manifestations incidence during COVID-19 infection varied between countries, a recent review showed a worldwide mean incidence of 1.7%. These manifestations are polymorphic, and vary dependently on the disease severity. Few pityriasis rosea (PR) and PR-like eruptions have been reported during COVID-19 infection.
is ?:annotates of
?:creator
?:journal
  • J._Eur._Acad._Dermatol._Venereol
?:license
  • unk
?:publication_isRelatedTo_Disease
?:source
  • WHO
?:title
  • Pityriasis rosea as a leading manifestation of COVID-19 infection
?:type
?:who_covidence_id
  • #951034
?:year
  • 2020

Metadata

Anon_0  
expand all